NDHnow.com - Drug Updates - New Indications


		Drug Updates \| New Indications

   Web Toolkit
   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

News Capsules

Drug Warnings

Herbal Spotlight

Nursing Links

Career Opportunities

Drug Info Bookstore

Feedback

Registration

Disclaimer

fosamprenavir
Lexiva	Pharmaceutical company: GlaxoSmithKline www.gsk.com

NEW INDICATION & DOSAGE
HIV-1 infection, taken with other antiretrovirals-- Treatment-naive adults: 1,400 mg P.O. daily with ritonavir 100 mg P.O. daily. Or, 700 mg P.O. b.i.d. with ritonavir 100 mg/day P.O. b.i.d.

Home - Guest Registry - Customer Service